|
Delayed
Australian S.E.
06:30:23 13/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.3700 AUD | -1.33% |
|
-2.63% | -43.08% |
| 07-30 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 07-21 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RECCE PHARMACEUTICALS LTD | Other Pharmaceuticals | -1.33% | -2.63% | -43.08% | -12.94% | -58.89% | 79.45M |  |  | |
- Stock Market
- Stocks
- RCE Stock
- Charts Recce Pharmaceuticals Ltd
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
